NCT03114527 2026-05-22Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)Fox Chase Cancer CenterPhase 2 Active not recruiting48 enrolled